BestCare Treatment Services is a licensed substance use treatment provider in Madras, OR, listed in the SAMHSA treatment directory. An intensive outpatient program lets clients attend structured treatment several days a week while living at home. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. Naltrexone is used to support recovery from opioid or alcohol use disorder. The program treats co-occurring mental health conditions alongside addiction. The facility reports accepting the Oregon Health Plan. Private health insurance is accepted. It serves children/adolescents, young adults, seniors.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Levels of care
OutpatientIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatment
Type of care
Substance use treatmentTreatment for co-occurring disorders plus serious mental illness (SMI) in adultsTreatment for co-occurring disorders plus serious emotional disturbance (SED) in children
Medications
Buprenorphine used in TreatmentNaltrexone used in Treatment
Payment accepted
Federal, or any government funding for substance use treatment programsIHS/Tribal/Urban (ITU) fundsMedicaidPrivate health insuranceCash or self-paymentState-financed health insurance plan other than MedicaidSAMHSA funding/block grants
Ages served
Children/AdolescentsYoung AdultsSeniors
Accreditation
State substance use treatment agencyCouncil on Accreditation (COA)
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
1059 NW Madras Highway, Buildings A, B, and C, Prineville, OR 97754
OutpatientIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsIHS/Tribal/Urban (ITU) funds
Residential/24-hour residentialLong-term residentialShort-term residentialFederal, or any government funding for substance use treatment programsIHS/Tribal/Urban (ITU) funds
OutpatientOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatmentFederal, or any government funding for substance use treatment programsMedicare